Skip to main content
Công ty Cổ phần Dược Hậu Giang logo

Công ty Cổ phần Dược Hậu Giang — Investor Relations & Filings

Ticker · DHG ISIN · VN000000DHG0 HSX Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2023-01-19 Earnings Release
Country VN Viet Nam
Listing HSX DHG

About Công ty Cổ phần Dược Hậu Giang

www.dhgpharma.com.vn

Công ty Cổ phần Dược Hậu Giang (DHG Pharma) is a leading pharmaceutical enterprise with over 50 years of experience. The company specializes in the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products, including both supportive and treatment medications. DHG Pharma emphasizes the application of high technology and international production standards to ensure product quality. Key brands include Telfor, Bocalex, Natto DHA, Hapacol, and Biofermin, serving a broad consumer base. Committed to public health, DHG Pharma actively engages in community health initiatives and strives to provide high-quality, accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
DHG: Giải trình KQKD quý 4/2022 so với cùng kỳ năm trước
Earnings Release Classification · 80% confidence The document is an explanatory disclosure of Q4/2022 and full‐year 2022 business results, providing key financial metrics (net sales, profit before tax, profit after tax) and commentary on drivers. It is an initial announcement of quarterly financial results (key highlights) rather than a full interim report with comprehensive statements or an annual audit report. Therefore, it fits the Earnings Release (ER) category. Q4 2022
2023-01-19 Vietnamese
DHG: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 30
Board/Management Information Classification · 92% confidence The document is a formal notification to the State Securities Commission and Ho Chi Minh Stock Exchange announcing a change in the company’s legal representative (General Director). It details the pre- and post-change information for the senior management role. This fits “Board/Management Information” (MANG): announcements of changes in the company’s board or senior management.
2023-01-04 Vietnamese
DHG: CBTT kế hoạch kinh doanh năm 2023
Regulatory Filings Classification · 78% confidence The document is an extraordinary information disclosure filed with the State Securities Commission and Ho Chi Minh Stock Exchange, detailing the company’s business plan for the next fiscal year pursuant to a Board resolution. It is a regulatory announcement/compliance filing rather than a full financial report or management change notice. It does not contain substantive financial statements or a full report, but rather a disclosure required by the exchange. Therefore it falls under the general Regulatory Filings category (RNS).
2022-12-06 Vietnamese
DHG: Thông báo thay đổi nhân sự công ty
Board/Management Information Classification · 90% confidence The document is a formal notification to the securities regulator and stock exchange about dismissal and appointment of the company’s top executives (CEO, COO, Deputy GMs, etc.). It contains no financial statements or results and specifically addresses changes in senior management positions. This matches the ‘Board/Management Information’ category.
2022-12-02 Vietnamese
DHG: CBTT thay đổi mô hình Công ty và loại BCTC
Regulatory Filings Classification · 88% confidence The document is an official announcement by DHG Pharmaceutical JSC to the State Securities Commission and the Ho Chi Minh Stock Exchange regarding changes in its corporate structure (dissolution of a subsidiary) and the type of financial statements to be disclosed. It is not a financial report itself (10-K, IR), not a management appointment, nor a capital raising or dividend notice. It is a statutory regulatory announcement about a corporate structure change. Therefore it fits under the generic “Regulatory Filings” category (RNS).
2022-11-15 Vietnamese
DHG: Thông báo về việc xử lý vi phạm về thuế
Regulatory Filings Classification · 85% confidence The document is an extraordinary information disclosure by DHG Pharmaceutical JSC to the State Securities Commission and Ho Chi Minh Stock Exchange concerning tax violations and penalties. It is not a financial report (no financial statements), not a management change, not an earnings release, nor any other specific category. It is a general regulatory announcement of a material event, so it falls under the fallback category for miscellaneous regulatory filings (RNS).
2022-11-11 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.